Black Rock Inc. Harmony Biosciences Holdings, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,835,243 shares of HRMY stock, worth $199 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,835,243
Previous 5,922,761
1.48%
Holding current value
$199 Million
Previous $199 Million
11.48%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRMY
# of Institutions
318Shares Held
42.8MCall Options Held
1.05MPut Options Held
310K-
Vanguard Group Inc Valley Forge, PA5.1MShares$173 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.69MShares$57.6 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.67MShares$56.8 Million0.02% of portfolio
-
State Street Corp Boston, MA1.65MShares$56.3 Million0.0% of portfolio
-
Lsv Asset Management Chicago, IL1.59MShares$54.3 Million0.1% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.01B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...